NATURAL HEALTH TRENDS CORP

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

NHTC$0.74-3.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

PART I

Item 1. Business Item 1A. Risk Factors

Item 1B. Unresolved Staff Comments (no text here)

Item 1C. Cybersecurity Item 2. Properties Item 3. Legal Proceedings

Item 4. Mine Safety Disclosures (no text here)

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 6. [Reserved] (no text here)

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Financial Statements and Supplementary Data Report of Independent Registered Public Accounting Firm (Marcum LLP, PCAOB ID No. 688)Consolidated Balance Sheets Consolidated Statements of Operations Consolidated Statements of Comprehensive Income Consolidated Statements of Stockholders’ Equity Item 8. Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements

Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure (no text here)

Item 9A. Controls and Procedures Item 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (no text here)

PART III

Item 10. Directors, Executive Officers and Corporate Governance (no text here)

Item 11. Executive Compensation (no text here)

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters (no text here)

Item 13. Certain Relationships and Related Transactions, and Director Independence (no text here)

Item 14. Principal Accountant Fees and Services (no text here)

PART IV

Item 15. Exhibits and Financial Statement Schedules Item 16. Form 10-K Summary Signatures Power of Attorney (see signature page)

Consolidated Balance Sheets

(In Thousands, Except Share Data)

	December 31,
	2024	2023
ASSETS
Current assets:
Cash and cash equivalents	$13,533	$56,178
Marketable securities	30,407	—
Inventories	3,272	4,293
Other current assets	3,771	3,758
Total current assets	50,983	64,229
Property and equipment, net	190	266
Operating lease right-of-use assets	2,498	3,319
Restricted cash	34	39
Deferred tax asset	382	369
Other assets	1,272	869
Total assets	$55,359	$69,091
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$895	$990
Income taxes payable	4,908	3,716
Accrued commissions	2,021	2,067
Other accrued expenses	1,425	1,170
Deferred revenue	6,428	6,166
Amounts held in eWallets	3,286	3,945
Operating lease liabilities	1,127	1,146
Other current liabilities	709	784
Total current liabilities	20,799	19,984
Income taxes payable	—	5,054
Deferred tax liability	174	135
Operating lease liabilities	1,514	2,318
Total liabilities	22,487	27,491
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	—	—
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2024 and 2023	13	13
Additional paid-in capital	84,901	84,695
Accumulated deficit	(26,344)	(17,703)
Accumulated other comprehensive loss	(1,301)	(1,069)
Treasury stock, at cost; 1,466,339 and 1,462,641 shares at December 31, 2024 and 2023, respectively	(24,397)	(24,336)
Total stockholders’ equity	32,872	41,600
Total liabilities and stockholders’ equity	$55,359	$69,091

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.